SFV HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Kaiser Permanente Appoints President for Panorama City and Antelope Valley
Patricia Clausen is the new senior vice president and area manager of Kaiser Permanente’s Panorama City/Antelope Valley service area.
Resonate Partners with Distributor
Cannabis wellness and lifestyle company Resonate Blends of Calabasas has selected Mars Distribution to distribute its Koan Cordial product line.
Amgen Asthma Drug Granted Priority Review by FDA
Amgen Inc. announced that the U.S. Food and Drug Administration accepted a biologics license application and granted priority review for Tezepelumab, an asthma drug developed in collaboration with AstraZeneca.
Former Glendale CEO Found Guilty of $250 Million Workers’ Comp Fraud
The chief executive of a Glendale medical imaging company was found guilty of fraudulently submitting claims worth more than $250 million through the state workers’ compensation system.
ImmunoCellular Therapeutics Applies to Stay on OTC Market
Westlake Village biotech company ImmunoCellular Therapeutics has applied for continued public quoting on the over-the-counter market to comply with amended Rule 15c2-11 under the Securities and Exchange Act.
MannKind Stock Jumps on Medicare Policy Change
MannKind Corp.’s shares closed up more than 11 percent after the announcement of a Medicare policy change that lifts a restriction on diabetic patients having to choose between two tools to manage the condition.
Second Sight Raises $57.5 Million in Public Offering
Visual prosthetic developer Second Sight Medical Products announced the closing of a secondary offering of common stock that raised $57.5 million in gross proceeds.
Adventist Health Simi Valley Partners on Up-Front Medical Payment Program
Adventist Health Simi Valley and MDsave have partnered on a new way for patients to save money as an increasing number of people pay out of pocket for health care.
Amgen Migraine Drug Aimovig Approved in Japan
Amgen Inc.’s migraine attack suppressant, Aimovig, has been granted marketing approval by the Japanese Ministry of Health, Labour and Welfare.
Quanta Subsidiary Signs Tony Hawk Endorsement Deal
Medolife Rx Inc., a subsidiary of Quanta Inc. in Burbank, has reached a brand endorsement agreement with skateboarding icon Tony Hawk.
MannKind to Co-Develop Lung Fibrosis Treatment
Mannkind Corp. has signed a collaboration agreement with Thirona Bio Inc. to further development of a new chemical owned by Thirona to treat lung fibrosis.
Amgen Lung Cancer Drug Approved by FDA
The U.S. Food and Drug Administration gave accelerated approval to Lumakras, a drug from Amgen Inc. for adult patients with non-small cell lung cancer.
LTC Sells Three Wisconsin Properties for $35 Million
Real estate investment trust LTC Properties, which specializes in health care property and senior housing investments, has announced a $35 million sale of three assisted living properties in Wisconsin.
Amgen Signs $1.25 Billion Deal to Develop Skin Treatment
Amgen Inc. on Tuesday announced a $1.25 billion deal with Kyowa Kirin Co. Ltd. to jointly develop and commercialize Kyowa’s treatment for atopic dermatitis, KHK4083.
Providence St. Joseph Hospital Chief Executive Steps Down
Kelly Linden stepped down as chief executive of Providence St. Joseph Medical Center in Burbank effective May 14.
Prev Next